Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth (CoolXenon2)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study examines the effect of inhaled xenon gas in the treatment of newborn infants with hypoxic-ischemic encephalopathy (HIE) in combination with cooling, which is the standard treatment for this condition. The hypothesis is that the xenon + cooling combination will produce better neuroprotection than the standard treatment of cooling alone.
| Condition | Intervention | Phase |
|---|---|---|
|
Hypoxic Ischaemic Encephalopathy |
Drug: xenon gas Device: Full body cooling |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth: Randomised Pilot Study |
- Amplitude Integrated Electroencephalogram (aEEG) grading [ Designated as safety issue: No ]Number of hours after birth when aEEG voltage has reached a normal or discontinuous normal pattern
- Brain MRI [ Time Frame: less than 2 weeks of age ] [ Designated as safety issue: No ]Magnetic Resonance Imaging findings at less than 2 weeks of age
| Estimated Enrollment: | 24 |
| Study Start Date: | May 2012 |
| Estimated Study Completion Date: | April 2014 |
| Estimated Primary Completion Date: | April 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 72h cooling + 18h xenon inhalation
Babies in poor condition at birth and referred to our neonatal unit for standard therapy of cooling to 33.5 degree C body temperature will be randomised to receive xenon gas at 50% concentration for 18 hours
|
Drug: xenon gas
Inhalation via endotracheal tube of 50% xenon for 18 hours
|
|
Active Comparator: Standard 72 h whole body cooling therapy
Whole body cooling therapy to rectal temperature of 33.5 degree Centigrade (standard therapy)
|
Device: Full body cooling
Cooling of baby to reduce rectal temperature to 33.5 degree Centigrade(standard treatment)
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Infants will be eligible for for the trial if the St Michael's hospital standard inclusion criteria for cooling and additional inclusion criteria for xenon administration are met.
St Michael's hospital standard inclusion criteria for standard hypothermia treatment of 72 hrs:
A: Neonates born at greater than 36 weeks gestation (estimated or clinical assessment) with at least ONE of the following:
- Apgar score of ≤5 at ten minutes after birth
- Continued need for resuscitation, including tracheal or mask ventilation, at ten minutes after birth
- Acidosis, defined as either umbilical cord pH or any arterial, venous or capillary pH within 60 minutes of birth less < 7.00
- Base deficit ≥16 mmol/L in umbilical cord blood sample or any blood sample within 60 minutes of birth (arterial or venous blood).
If the infant meets criterion A then assess for neurological abnormality using criterion B and C (by trained personnel):
B: Moderate or Severe encephalopathy as evidenced by any of the following:
- Altered state of consciousness (reduced or absent responses or pathological irritability and hyper responsive and at least ONE or more of the following:
- Hypotonia
- Abnormal reflexes including oculomotor or pupillary abnormalities
- Absent or weak suck
- Clinical seizures, as recorded by trained personnel
And
C: At least 30 minutes duration of amplitude-integrated electroencephalography (aEEG) recording that shows abnormal background aEEG activity. The decision to cool is based on the worst 30 min section of the aEEG, not the best [35] or seizures (clinical or electrical) thus meeting ONE of the following:
- Normal background with some (> 5 min) electrical seizure activity
- Moderately abnormal activity (upper margin of trace >10μV and lower margin <5μV)
- Suppressed activity (upper margin of trace <10μV and lower margin of trace <5μV)
- Definite seizure activity
Additional inclusion criteria for xenon:
Before being considered for additional inhaled xenon therapy via the breathing gas mixture, the infant would need to meet further additional entry criteria (all must be met):
- Intubated, ventilated, sedated, being cooled
- ≤ 5 hours old
- Any seizures under control
- Weight > 2nd centile for gestational age
- Stable cardiovascular parameters; Mean arterial pressure >40mmHg.
- Oxygen requirement via mechanical ventilator ≤ 40%.
- Positive End Expiratory Pressure (PEEP) requirement ≤ 6cm H2O
- Arterial pCO2 within acceptable range (<7kPa)
- Absence of major congenital abnormalities, imperforate anus and in particular any bowel obstruction, congenital abnormalities suggestive of chromosomal anomaly or other syndromes that include brain dysgenesis. Congenital syndromes affecting the brain should be excluded when diagnosed.
Exclusion criteria for cooling in the CoolXenon2 study
- Infants expected to be greater than 3 hours of age at the time of starting cooling treatment.
- Futility. Where prognosis is considered to be hopeless e.g. no cardiac output for 20 minutes.
Contacts and Locations| Contact: Marianne Thoresen, Professor | +44117 342 5226 | carol.s.bond@bristol.ac.uk |
| Contact: Carol Bond | +44117 342 5226 | carol.s.bond@bristol.ac.uk |
| United Kingdom | |
| St Michael's Hospital | Recruiting |
| Bristol, Avon, United Kingdom, BS2 8EG | |
| Principal Investigator: | Marianne Thoresen, Professor | University of Bristol |
More Information
Publications:
| Responsible Party: | United Bristol Healthcare NHS Trust |
| ClinicalTrials.gov Identifier: | NCT01545271 History of Changes |
| Other Study ID Numbers: | CH/2011/3799, 2011-005397-34, 12/SW/0010 |
| Study First Received: | February 29, 2012 |
| Last Updated: | January 31, 2013 |
| Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency United Kingdom: National Health Service United Kingdom: Research Ethics Committee |
Keywords provided by United Bristol Healthcare NHS Trust:
|
Xenon Hypothermia Hypoxic Ischemic Encephalopathy Newborn |
Term Neuroprotection Cooling HIE |
Additional relevant MeSH terms:
|
Brain Ischemia Ischemia Brain Damage, Chronic Delirium Encephalitis Hepatic Encephalopathy Neurotoxicity Syndromes Brain Injuries Hypoxia-Ischemia, Brain Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases |
Pathologic Processes Confusion Neurobehavioral Manifestations Neurologic Manifestations Signs and Symptoms Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders Central Nervous System Viral Diseases Virus Diseases Central Nervous System Infections Liver Failure Hepatic Insufficiency Liver Diseases Digestive System Diseases Brain Diseases, Metabolic |
ClinicalTrials.gov processed this record on May 23, 2013